Most people won't need a COVID-19 vaccine booster shot for years, vaccination experts predict

The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is meeting next week to discuss whether immunocompromised Americans should be authorized to receive a third dose of COVID-19 vaccine, and Pfizer said last week it will seek regulatory approval for an eventual third booster shot of its vaccine amid the rapidly spreading Delta variant. Israel said this week it will begin administering a third Pfizer dose to severely immunocompromised adults, and Britain has announced a plan to administer booster shots beginning in September.
The rapid spread of the Delta mutation among unvaccinated pockets of the U.S. combined with Pfizer's announcement "has unleashed third-dose panic among the vaccinated," Politico reports. But global public health officials are outraged that vaccine-rich countries would consider third shots before health care workers in many countries have gotten their first dose of a COVID-19 vaccine. And most U.S. public health and government officials say people won't need a booster shot now or anytime soon.
"There's no evidence right now that the general population needs a booster dose because we're not seeing evidence of waning immunity or substantially reduced effectiveness against the Delta variant," William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, tells Politico. "I think for most people, outside those special populations, the immunocompromised and maybe the elderly — I think most people's immunity is going to last years, to be honest." He said if a variant manages to evade the vaccines, a booster shot may be needed, but he guessed it will be three or four years, or longer, before most people need an extra dose.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I haven't seen evidence that a booster would be indicated for anybody, including the immunocompromised," Helen Boucher, an infectious-disease doctor at Tufts Medical Center in Boston, tells The Washington Post. She said the best way to protect immunocompromised people is to make sure everyone around them is vaccinated.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The Arab League's plan for Gaza
The Explainer Arab leaders reject Donald Trump's proposals to move Palestinians out of Gaza to create 'Middle East Riviera'
By Elizabeth Carr-Ellis, The Week UK Published
-
Thrilling must-see operas for 2025
The Week Recommends From Carmen to Peter Grimes, these are the UK's top productions
By Irenie Forshaw, The Week UK Published
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published